Peroxisomal Pathways, their Role in Neurodegenerative Disorders and Therapeutic Strategies

作者: Patrizia Risé , Rita Paroni , Anna Petroni

DOI: 10.1016/B978-0-12-410527-0.00003-X

关键词:

摘要: X-linked adrenoleukodystrophy (X-ALD), the most frequent peroxisomal disease, is due to a mutation in ABCD1 gene encoding for protein important transport of acyl chains into peroxisomes further oxidation. This leads defect this transporter and an accumulation very long chain fatty acids (VLCFA), particular 26:0, plasma tissues, including brain. The high concentration saturated VLCFA alters structure functions cell membranes, toxic effects are attributable induction oxidative stress inflammation (also associated with autoimmune mechanisms). Dietary intervention therapy have provided encouraging results, albeit sometimes conflicting findings different clinical studies. Elucidation molecular mechanisms X-ALD should aid developing new strategies, e.g. synergistic approach acting on causes pharmacological therapies X-ALD.

参考文章(80)
Patrick Aubourg, Gene therapy for disorders of the central nervous system. Handbook of Clinical Neurology. ,vol. 113, pp. 1859- 1866 ,(2013) , 10.1016/B978-0-444-59565-2.00056-3
Masumi Ito, Benjamin M. Blumberg, David J. Mock, Andrew D. Goodman, Ann B. Moser, Hugo W. Moser, Kirby D. Smith, James M. Powers, Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. Journal of Neuropathology and Experimental Neurology. ,vol. 60, pp. 1004- 1019 ,(2001) , 10.1093/JNEN/60.10.1004
Gérard Lizard, Olivier Rouaud, Jean Demarquoy, Mustapha Cherkaoui-Malki, Luigi Iuliano, None, Potential Roles of Peroxisomes in Alzheimer's Disease and in Dementia of the Alzheimer's Type Journal of Alzheimer's Disease. ,vol. 29, pp. 241- 254 ,(2012) , 10.3233/JAD-2011-111163
Ann B. Moser, David S. Jones, Gerald V. Raymond, Hugo W. Moser, Plasma and red blood cell fatty acids in peroxisomal disorders Neurochemical Research. ,vol. 24, pp. 187- 197 ,(1999) , 10.1023/A:1022549618333
Michael Brenner, Anne B. Johnson, Odile Boespflug-Tanguy, Diana Rodriguez, James E. Goldman, Albee Messing, Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nature Genetics. ,vol. 27, pp. 117- 120 ,(2001) , 10.1038/83679
Waylon T. Hunt, Amit Kamboj, Hope D. Anderson, Christopher M. Anderson, Protection of cortical neurons from excitotoxicity by conjugated linoleic acid Journal of Neurochemistry. ,vol. 115, pp. 123- 130 ,(2010) , 10.1111/J.1471-4159.2010.06908.X
Manuela Martínez, Elida Vázquez, M Teresa García-Silva, Javier Manzanares, José M Bertran, Francisco Castelló, Isabel Mougan, None, Therapeutic effects of docosahexaenoic acid ethyl ester in patients with generalized peroxisomal disorders The American Journal of Clinical Nutrition. ,vol. 71, ,(2000) , 10.1093/AJCN/71.1.376S
Robert W. Ledeen, Goutam Chakraborty, Praveen Mekala, Daniel Yahya, Gusheng Wu, Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. Journal of Neurochemistry. ,vol. 78, pp. 736- 745 ,(2001) , 10.1046/J.1471-4159.2001.00456.X